One of the country’s top pharmacy benefit managers has plans to launch a new pricing model to foster more transparency between it and its clients, but the founder of a coalition of smaller PBMs is urging drug industry stakeholders and policymakers to be wary of the move, which he alleges will still rely on a spread-pricing business model. Beginning Jan. 1, 2025, Optum Rx will offer to drug benefit plan sponsors a new alternative pricing approach aimed at ensuring plan...